- Nachrichtendetail
-
28.06.2024 12:42:39 - dpa-AFX: *AB SCIENCE: CHMP ADOPTS NEGATIVE OPINION ON APPLICATION FOR CONDITIONAL MARKETING AUTHORIZATION OF MASITINIB IN ALS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AB SCIENCE S.A. EO-,01 | A1CXBG | Frankfurt | 0,971 | 30.09.24 08:10:55 | +0,040 | +4,30% | 1,010 | 1,024 | 0,971 | 0,931 |
